This inventor holds 2 USPTO granted patents. Top assignee: Dr. Karl Thomae Gmbh. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Inventor Cora Klein
Introduction
Cora Klein is a notable inventor based in Offenbach, Germany, recognized for her significant contributions to the field of biosynthesis and chemical compounds. With a total of two patents to her name, Klein has made remarkable strides in developing synthetic processes that enhance the production of complex polypeptides.
Latest Patents
Cora Klein's latest patents encompass advanced biosynthetic processes for the preparation of chemical compounds. Her notable inventions describe a bacterial host transformed by a plasmid coding for a polypeptide precursor, wherein the host contains a multi-enzyme complex that reacts with the expressed polypeptide precursor. This innovative approach leads to the production of polypeptides that feature at least one dehydroamino acid or a lanthionine bridge.
Among her contributions are details on the process for creating polypeptides like gallidermin, as well as the description of a plasmid capable of transforming a bacterial host. Additionally, her patents disclose recombinant DNA molecules specifying Epi B, Epi C, Epi D, Epi P, and Epi Q, each serving as crucial enzymes in the biosynthesis of the lantibiotic epidermin.
Career Highlights
Throughout her career, Cora Klein has worked with esteemed organizations such as Dr. Karl Thomae GmbH, where she honed her expertise and contributed to groundbreaking research in her field. Her innovative work, particularly in chemical synthesis, has established her as a prominent figure in biotechnology.
Collaborations
During her professional journey, Klein collaborated with eminent scientists like Karl-Dieter Entian and Friedrich Gotz. These collaborations have enriched her research and propelled her contributions to the scientific community, enhancing the understanding of biosynthetic pathways and their applications.
Conclusion
Cora Klein's inventive spirit and dedication to advancing the understanding of biochemical processes have resulted in vital patents that push the boundaries of innovation in biosynthesis. Her contributions to the production of complex polypeptides reflect her commitment to shaping the future of chemical compounds and biotechnological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile